John Tang

John Tang has over 18 years of work experience in various roles within the pharmaceutical and healthcare industries. John currently serves as the VP, Global Head of Program Management at Ascentage Pharma, a position they have held since 2018. Prior to that, they worked at Genentech as the TA Head of Medical Affairs from 2016 to 2018. From 2015 to 2016, John was the Head of Department Quality Clinical Data at EMHS. John also held the role of Sr. Director Clinical at IQVIA (Quintiles) from 2014 to 2015 and Sr. Director Phase II-IV at Syneos Health (inVentiv Health) from 2013 to 2014. Before that, they worked at Pfizer as the Director of Global Clinical & Medical Affairs from 2010 to 2013. John's experience also includes a role as the Director (Department Head) of Early Development at ICON Clinical Research from 2007 to 2009. John started their career at the Ludwig Institute for Cancer Research as a Manager/Consultant Clinical Trials from 2002 to 2009. Additionally, they worked as a Consultant (Moonlighting) at The SAS Institute from 2003 to 2004 and as a Manager of Clinical Affairs at Zimmer from 2000 to 2002.

John Tang began their education in 1998 at UC San Diego, where they pursued Bioengineering and Biomedical Engineering. After completing this program in 1999, they then went on to pursue a Doctor of Philosophy (Ph.D.) degree at the University of Houston. While no specific dates are provided, it can be inferred that their enrollment at the University of Houston happened after their time at UC San Diego. Additionally, John Tang has also attended Texas A&M University, although no further details regarding degree or field of study are provided. Lastly, they obtained a Master of Science (M.Sc.) degree from National Sun Yat-Sen University. In terms of certifications, John Tang received a certification as a Certified Professional from Oracle in the year 2000.